This study looks at whether using a cosmeceutical called P-TIOX together with a treatment called Tixel can reduce fine lines and wrinkles around the eyes better than Tixel treatment alone. Tixel is an FDA-approved device that uses heat to improve skin texture and firmness. P-TIOX is a topical product with ingredients that may help improve the skin's appearance and elasticity.

One side of the face will be treated with both P-TIOX and Tixel, while the other side will receive Tixel only. The study will last about 9 weeks and will include several treatments and evaluations using photos and expert assessments.

Participants may notice improvement in the skin around their eyes. The results will help doctors understand if this combination treatment is more effective.

This clinical trial is designed to evaluate the combined effect of a topical cosmeceutical, P-TIOX, with fractional thermal treatment using the Tixel device, on improving fine lines and wrinkles around the eyes (periocular region). The study will compare the outcomes of this combination therapy to Tixel treatment alone using a split-face design, where one side of each participant's face receives both treatments and the other side receives only Tixel.

Tixel is an FDA-cleared, fractional thermal-mechanical device that delivers controlled heat energy to the skin to stimulate collagen production and improve skin texture and elasticity. P-TIOX is an over-the-counter topical product containing a blend of peptides, acids, vitamins, and extracts that have been clinically shown to improve skin texture, elasticity, and the appearance of wrinkles.

The study will enroll 20 adult participants aged 30 years or older who have mild to moderate periocular wrinkles. Participants will be randomized to apply P-TIOX daily on one side of the face starting one week before the first Tixel treatment and continuing for the duration of the 9-week study period. Both sides will receive three standardized Tixel treatments spaced over four weeks.

Clinical outcomes will be assessed objectively by standardized photography using the Canfield Visia imaging system and analyzed by a blinded board-certified dermatologist using validated wrinkle severity scales. Subjective outcomes will be measured through patient self-assessment questionnaires. Safety will be monitored through adverse event reporting throughout the study.

This study aims to determine if combining P-TIOX with Tixel treatment provides superior improvement in periocular fine lines and wrinkles compared to Tixel alone, offering a potentially enhanced minimally invasive treatment option for facial rejuvenation.

Inclusion Criteria:

• Severity of 2, 3, or 4 based on the 5-point severity scale of both periocular areas
• 30 years of age or older
• Willingness to comply with study visits
• Willingness to discontinue use of other topical cosmeceuticals/retinoids to the periocular region for the duration of the study

Exclusion Criteria:

• Pregnant or breastfeeding
• Prior treatment with periocular laser, energy-based devices, neuromodulators, or dermal fillers within the past six months
• Prior surgical intervention in the periocular region within the past twelve months
• Use of topical retinoids in the periocular area within the past four weeks
• Known hypersensitivity to any component of P-TIOX
• Presence of active dermatologic or ocular disease in the treatment area
• Active systemic infection
• Active cold sore/herpes labialis infection

Available upon request

Data will be available for 7 years after the conclusion of the study.

Data will be available upon request.